Literature DB >> 1085334

Induction of an antibody response in cultures of human peripheral blood lymphocytes.

A L Luzzati, M J Taussig, T Meo, B Pernis.   

Abstract

A culture system is descirbed which provides adequate conditions for in vitro immunization of humand peripheral blood lymphocytes to heterologous erythrocytes. Making use of this method we could obtain, with a number of different donors, an antibody response which peaked at about day 8 of culture with 30-300 plaque-forming cells (PFC) per 10(6) input lymphocytes. However, in a number of experiments poor or negative results were obtained, even with donors that had previously given good response. This variability in the results was shown not to be due to a too low number of precursor cells present in the blood and could be overcome by treating the cells, before initiation of the culture, with a factor produced by mouse T cells educated to sheep erythrocytes (SRBC). Under these conditions a PFC responce was obtained which peaked at about day 8 and which in some experiments could be as high as 20,000 PFC per 10(6) input lymphocytes. Paralleling the increase in PFC was an increase in cell number. The cells recovered from the treated cultures were at all times more numerous than in the nontreated cultures. The height of both the proliferative and antibody-producing responses varied from experiment to experiment, a higher proliferative response, accompanying a higher PFC response. Although the mechanisms that are at the basis of the antibody response in vitro described in this paper still need to be clarified, this system may become a useful tool in studying the immune response in man.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1085334      PMCID: PMC2190405          DOI: 10.1084/jem.144.3.573

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  In vitro antibody formation by human tonsil lymphocytes.

Authors:  T Watanabe; K Yoshizaki; T Yagura; Y Yamamura
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

2.  T cell factor which can replace T cells in vivo.

Authors:  M J Taussig
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

3.  Antibody response by rabbit peripheral blood lymphocytes in microcultures.

Authors:  A L Luzzati; I Lefkovits; B Pernis
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  Production of antibody to sheep red blood cells by human tonsil cells in vitro.

Authors:  M K Hoffman; D Schmidt; H F Oettgen
Journal:  Nature       Date:  1973-06-15       Impact factor: 49.962

5.  In vitro reconstitution of T cell deficient mouse spleen cells by co-cultivation with human lymphocytes.

Authors:  J J Farrar
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

Review 6.  Separate signals for the initiation of proliferation and differentiation in the b cell response to antigen.

Authors:  R W Dutton
Journal:  Transplant Rev       Date:  1975

7.  Suppressor cells in rabbit peripheral blood.

Authors:  A L Luzzati; L Lafleur
Journal:  Eur J Immunol       Date:  1976-02       Impact factor: 5.532

8.  The xenogeneic effect. I. Antigen and mitogen-stimulated human lymphocytes produce a non-antigen-specific factor which reconstitutes the antibody response of T cell-deficient mouse spleen cells.

Authors:  J J Farrar
Journal:  J Immunol       Date:  1975-11       Impact factor: 5.422

9.  IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes.

Authors:  T A Platts-Mills; K Ishizaka
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

10.  Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes.

Authors:  R S Geha; E Schneeberger; F S Rosen; E Merler
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  10 in total

1.  Antibody formation by human tonsil cells in vitro.

Authors:  Z Baumöhl; B Kellerhals; W Stolp; I Lefkovits
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

Review 2.  Antigen-specific T-cell factors.

Authors:  M J Taussig
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

3.  Selective production of human antigen specific helper factor from normal volunteers: implications for human Ir genes.

Authors:  N J Zvaifler; M Feldmann; S Howie; J Woody; A Ahmed; R Hartzman
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

4.  Marmoset species variation in the humoral antibody response: in vivo and in vitro studies.

Authors:  N Gengozian; J R Kateley; D A Nickerson
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

5.  Induction of plaque-forming cells in human blood lymphocytes cultured in the presence of antigen and Epstein-Barr virus: a study with normal donors and infectious mononucleosis patients.

Authors:  A L Luzzati; I Heinzer; H Hengartner; M H Schreier
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

6.  Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency.

Authors:  H G Herrod; R H Buckley
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Induction of antibody to foot-and-mouth disease virus in presensitized mouse spleen cell cultures.

Authors:  T Collen; K C McCullough; T R Doel
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.

Authors:  B J Weill; M L Renoux
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Induction of human antigen-specific and non-specific helper factors in vitro.

Authors:  F Kantor; M Feldmann
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

10.  Suppression of antibody responses in humans infected with Trypanosoma cruzi.

Authors:  D S Cunningham; M Grogl; R E Kuhn
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.